Journal
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
Volume 14, Issue 2, Pages 219-233Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCEP.120.009203
Keywords
atrial fibrillation; bradycardia; defibrillator; heart failure; sarcoidosis; tachycardia
Categories
Ask authors/readers for more resources
Cardiac sarcoidosis, a component of a multiorgan granulomatous disease, is being increasingly recognized due to heightened awareness and new diagnostic tests like cardiac magnetic resonance imaging and F-18-fluorodeoxyglucose positron emission tomography scans. Early diagnosis using these tools is crucial for potentially life-saving measures, and treatment options including those related to heart failure and disease mechanisms play an important role in patient care.
Cardiac sarcoidosis is a component of an often multiorgan granulomatous disease of still uncertain cause. It is being recognized with increasing frequency, mainly as the result of heightened awareness and new diagnostic tests, specifically cardiac magnetic resonance imaging and F-18-fluorodeoxyglucose positron emission tomography scans. The purpose of this case-based review is to highlight the potentially life-saving importance of making the early diagnosis of cardiac sarcoidosis using these new tools and to provide a framework for the optimal care of patients with this disease. We will review disease mechanisms as currently understood, associated arrhythmias including conduction abnormalities, and atrial and ventricular tachyarrhythmias, guideline-directed diagnostic criteria, screening of patients with extracardiac sarcoidosis, and the use of pacemakers and defibrillators in this setting. Treatment options, including those related to heart failure, and those which may help clarify disease mechanisms are included.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available